According to a number of ** reports, American entrepreneur Elon Musk said on the 19th local time that about the first human transplant of a brain-computer interface device carried out by his brain-computer interface company "Neural Connection", the transplant "seems to have been completely **, and there are no adverse reactions".
Elon Musk said that the transplant can already move the mouse through the brain. Currently, Neural Connections is trying to get him to press the mouse as much as he can with his mind, including moving the mouse up and down.
Elon Musk, an American entrepreneur: It's going well at the moment, the transplant seems to be recovering well, and can control the mouse movement around the screen through the brain's mind. We're trying to get the patient to press the mouse as much as they can with their mind, which is what we're doing, like clicking the left mouse button, the right mouse button, moving the mouse up and down. Overall, progress has been very good.
On January 29, Elon Musk said that Neural Connections had performed the first human transplant of a brain-computer interface device on January 28. According to him, Neural Connect's first brain-computer interface product is called "Telepathy", and after the brain is implanted in the device, it can control mobile phones, computers, and almost all devices through them just by using their minds. People who have lost the function of their limbs will be the first users of this product.
Founded in 2016, Neural Connectivity focuses on the research and development of implantable brain-computer interface devices. The company said that the device, implanted in the brain, can read brain activity signals, hoping to use it to ** memory loss, cervical spinal cord injury and other neurological diseases, help paralyzed people regain the ability to communicate with the outside world, and even walk again. In May last year, the company received approval from the U.S. Food and Drug Administration to initiate human clinical trials of brain implant devices. In September of the same year, the recruitment of volunteers for clinical trials began.
Neural Connections is facing scrutiny over security concerns
However, Neural Connections has also faced scrutiny from the relevant authorities because of the safety of related research. In November last year, four members of the U.S. Congress signed a letter to the U.S.** and the Exchange Commission, asking the agency to review the "Neural Connection" company. In the letter, they said that records of experiments conducted on monkeys by Neural Connections showed that the brain-implanted device adversely affected the health of the animals, showing symptoms such as paralysis, seizures and brain swelling, and that at least 12 young and healthy monkeys were euthanized after participating in the experiments, while Musk downplayed investors' concerns about the results of his animal trials. Four members of the U.S. Congress believe that the brain implant device developed by the company "Neural Connection" misled investors about safety issues, and Musk may be guilty of fraud.